CoChat

The influence of personality traits on the placebo/nocebo response

Open access
Kern, Alexandra, Kramm, Christoph, Witt, Claudia M., Barth, Jürgen · 2020 · Journal of Psychosomatic Research
Cited by 117

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

OBJECTIVE Some people might be more prone to placebo and nocebo responses than others depending on their personality traits. We aimed to provide a systematic review on the influence of personality traits on placebo and nocebo responses in controlled and uncontrolled studies. METHODS We conducted a systematic literature search in the databases CINAHL, AMED, PsycINFO and EMBASE for relevant publications published between January 1997 and March 2018. For all included papers, we conducted an additional forward search. RESULTS After screening 407 references, we identified 24 studies. The Big Five (i.e., neuroticism, extraversion, openness to experience, agreeableness and conscientiousness) and optimism were the most frequently investigated personality traits. Several studies found a positive association between optimism and the placebo response. Furthermore, we found that higher anxiety was associated with increased nocebo responses. CONCLUSION Evidence points to a possible association between optimism and the placebo response. Therefore, further emphasising the investigation of the influence of optimism on the placebo/nocebo response seems warranted. For clinical practice, the impact of anxiety on the nocebo response might be important to identify patients who might be more prone to experiencing side effects of medical treatments.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jpsychores.2019.109866

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Research works printed but not linked: 45

  1. Häuser, 2012, Nocebo phenomena in medicine: their relevance in everyday clinical practice, Dtsch. Arztebl. Int., 109, 459
  2. Rutherford, 2013, A model of placebo response in antidepressant clinical trials, Am. J. Psychiatry, 170, 723, 10.1176/appi.ajp.2012.12040474 · DOI · Paper page
  3. Rief, 2008, The power of expectation–understanding the placebo and nocebo phenomenon, Soc. Personal. Psychol. Compass, 2, 1624, 10.1111/j.1751-9004.2008.00121.x · DOI · Paper page
  4. Peciña, 2014, FAAH selectively influences placebo effects, Mol. Psychiatry, 19, 385, 10.1038/mp.2013.124 · DOI
  5. Weimer, 2015, Placebo effects in psychiatry: mediators and moderators, Lancet Psychiatry, 2, 246, 10.1016/S2215-0366(14)00092-3 · DOI · Paper page
  6. Bartels, 2016, Placebo and nocebo effects on itch: effects, mechanisms, and predictors, Eur. J. Pain, 20, 8, 10.1002/ejp.750 · DOI
  7. Bialosky, 2010, Individual expectation: an overlooked, but pertinent, factor in the treatment of individuals experiencing musculoskeletal pain, Phys. Ther., 90, 1345, 10.2522/ptj.20090306 · DOI · Paper page
  8. Enck, 2008, New insights into the placebo and Nocebo responses, Neuron, 59, 195, 10.1016/j.neuron.2008.06.030 · DOI · Paper page
  9. Kaptchuk, 2008, Do “placebo responders” exist?, Contemp Clin Trials, 29, 587, 10.1016/j.cct.2008.02.002 · DOI
  10. Jakšić, 2013, Does personality play a relevant role in the placebo effect?, Psychiatr. Danub., 25, 0
  11. Horing, 2014, Prediction of placebo responses: a systematic review of the literature, Front. Psychol., 5, 1079, 10.3389/fpsyg.2014.01079 · DOI
  12. Darragh, 2015, Who responds to placebos? Considering the “placebo personality” via a transactional model, Psychol. Health Med., 20, 287, 10.1080/13548506.2014.936885 · DOI
  13. Khan, 2005, Magnitude of placebo response and drug–placebo differences across psychiatric disorders, Psychol. Med., 35, 743, 10.1017/S0033291704003873 · DOI
  14. Kirsch, 2002, The emperor’s new drugs: an analysis of antidepressant medication data submitted to the US Food and Drug Administration, Prev. Treat., 5, 23a
  15. Enck, 2009, Der Placeboeffekt in der Medizin, Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz, 52, 635, 10.1007/s00103-009-0849-x · DOI
  16. Laidlaw, 2005, Low self-directedness (TCI), mood, schizotypy and hypnotic susceptibility, Pers. Individ. Differ., 39, 469, 10.1016/j.paid.2005.01.025 · DOI
  17. Beedie, 2008, Identification of placebo responsive participants in 40km laboratory cycling performance, J. Sports Sci. Med., 7, 166
  18. Beissner, 2015, Placebo-induced somatic sensations: a multi-modal study of three different placebo interventions, PLoS One, 10, 10.1371/journal.pone.0124808 · DOI
  19. Darragh, 2014, Investigating the ‘placebo personality’ outside the pain paradigm, J. Psychosom. Res., 76, 414, 10.1016/j.jpsychores.2014.02.011 · DOI
  20. De Pascalis, 2017, The behavioural approach system and placebo analgesia during cold stimulation in women: a low-resolution brain electromagnetic tomography (LORETA) analysis of startle ERPs, Pers. Individ. Differ., 118, 56, 10.1016/j.paid.2017.03.003 · DOI
  21. Geers, 2007, Further evidence for individual differences in placebo responding: an interactionist perspective, J. Psychosom. Res., 62, 563, 10.1016/j.jpsychores.2006.12.005 · DOI
  22. Corsi, 2017, Placebo and Nocebo effects: the advantage of measuring expectations and psychological factors, Front. Psychol., 8, 308, 10.3389/fpsyg.2017.00308 · DOI · Paper page
  23. Geers, 2010, Dispositional optimism predicts placebo analgesia, J. Pain, 11, 1165, 10.1016/j.jpain.2010.02.014 · DOI · Paper page
  24. Hyland, 2007, Dispositional predictors of placebo responding: a motivational interpretation of flower essence and gratitude therapy, J. Psychosom. Res., 62, 331, 10.1016/j.jpsychores.2006.10.006 · DOI
  25. Rosén, 2017, Effects of subtle cognitive manipulations on placebo analgesia – an implicit priming study, Eur. J. Pain, 21, 594, 10.1002/ejp.961 · DOI
  26. Yu, 2014, Placebo analgesia and reward processing: integrating genetics, personality, and intrinsic brain activity, Hum. Brain Mapp., 35, 4583, 10.1002/hbm.22496 · DOI
  27. Sullivan, 2008, Catastrophizing and treatment outcome: differential impact on response to placebo and active treatment outcome, Contemp. Hypn., 25, 129, 10.1002/ch.365 · DOI
  28. Aslaksen, 2015, Fear of pain potentiates nocebo hyperalgesia, J. Pain Res., 8, 703, 10.2147/JPR.S91923 · DOI
  29. Szemerszky, 2010, Polluted places or polluted minds? An experimental sham-exposure study on background psychological factors of symptom formation in ’Idiophatic environmental intolerance attributed to electromagnetic fields, Int. J. Hyg. Environ. Health, 213, 387, 10.1016/j.ijheh.2010.05.001 · DOI
  30. Webster, 2018, Medicine-related beliefs predict attribution of symptoms to a sham medicine: a prospective study, Br. J. Health Psychol., 23, 436, 10.1111/bjhp.12298 · DOI
  31. Witthöft, 2013, Are media warnings about the adverse health effects of modern life self-fulfilling? an experimental study on idiopathic environmental intolerance attributed to electromagnetic fields (IEI-EMF), J. Psychosom. Res., 74, 206, 10.1016/j.jpsychores.2012.12.002 · DOI · Paper page
  32. Corsi, 2017, Placebo and Nocebo effects: the advantage of measuring expectations and psychological factors, Front. Psychol., 8, 308, 10.3389/fpsyg.2017.00308 · DOI · Paper page
  33. Link, 2006, Placebo/nocebo symptom reporting in a sham herbal supplement trial, Eval Health Prof, 29, 394, 10.1177/0163278706293403 · DOI
  34. Staats, 2001, The additive impact of anxiety and a placebo on pain, Pain Med., 2, 267, 10.1046/j.1526-4637.2001.01046.x · DOI
  35. Van Laarhoven, 2011, Induction of nocebo and placebo effects on itch and pain by verbal suggestions, Pain, 152, 1486, 10.1016/j.pain.2011.01.043 · DOI · Paper page
  36. Nevelsteen, 2007, Effects of information and 50 Hz magnetic fields on cognitive performance and reported symptoms, Bioelectromagnetics, 28, 53, 10.1002/bem.20265 · DOI
  37. Put, 2004, Negative affectivity and the influence of suggestion on asthma symptoms, J. Psychosom. Res., 57, 249, 10.1016/S0022-3999(03)00541-5 · DOI
  38. Howick, 2018, Rapid overview of systematic reviews of nocebo effects reported by patients taking placebos in clinical trials, Trials, 19, 674, 10.1186/s13063-018-3042-4 · DOI
  39. Scheier, 1987, Dispositional optimism and physical well-being: the influence of generalized outcome expectancies on health, J. Pers., 55, 169, 10.1111/j.1467-6494.1987.tb00434.x · DOI · Paper page
  40. Abhishek, 2013, Mechanisms of the placebo response in pain in osteoarthritis, Osteoarthr. Cartil., 21, 1229, 10.1016/j.joca.2013.04.018 · DOI
  41. Planès, 2016, The nocebo effect of drugs, Pharmacol. Res. Perspect., 4, 10.1002/prp2.208 · DOI · Paper page
  42. Crichton, 2014, The link between health complaints and wind turbines: support for the nocebo expectations hypothesis, Front. Public Health, 2, 220, 10.3389/fpubh.2014.00220 · DOI
  43. Kelley, 2012, Open-label placebo for major depressive disorder: a pilot randomized controlled trial, Psychother. Psychosom., 81, 10.1159/000337053 · DOI · Paper page
  44. Carvalho, 2016, Open-label placebo treatment in chronic low back pain: a randomized controlled trial, Pain, 157, 2766, 10.1097/j.pain.0000000000000700 · DOI · Paper page
  45. Locher, 2019, Open-label placebo response – does optimism matter? a secondary-analysis of a randomized controlled trial, J. Psychosom. Res., 116, 25, 10.1016/j.jpsychores.2018.11.009 · DOI

Cited by

See all 117

Metadata

Authors
Kern, A., Kramm, C., Witt, C. M., & Barth, J.
Venue
Journal of Psychosomatic Research
Publisher
Elsevier BV
Published
2020-01
Volume
128
Pages
109866
ISSN
0022-3999 (ISSN-L)
OpenAlex
W2986989334
Cited by
117
References
17
FWCI
5.41
Type
journal article
Language
en
Open access
green
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (105319_159833)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The influence of personality traits on the placebo/nocebo response. https://app.cochat.ai/papers/10.1016/j.jpsychores.2019.109866
The paper
Kern, A., Kramm, C., Witt, C. M., & Barth, J. (2020). The influence of personality traits on the placebo/nocebo response. Journal of Psychosomatic Research. https://doi.org/10.1016/j.jpsychores.2019.109866

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.